Order Article Reprints

Aboudaram A, Chaltiel L, Pouessel D, Graff-Cailleaud P, Benziane-Ouaritini N, Sargos P, Schick U, Créhange G, Cohen-Jonathan Moyal E, Chevreau C, et al. Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis. Cancers. 2023; 15(4):1161. https://doi.org/10.3390/cancers15041161

Aboudaram, Amélie, Léonor Chaltiel, Damien Pouessel, Pierre Graff-Cailleaud, Nicolas Benziane-Ouaritini, Paul Sargos, Ulrike Schick, Gilles Créhange, Elizabeth Cohen-Jonathan Moyal, Christine Chevreau, and et al. 2023. "Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis" Cancers 15, no. 4: 1161. https://doi.org/10.3390/cancers15041161

Aboudaram, A., Chaltiel, L., Pouessel, D., Graff-Cailleaud, P., Benziane-Ouaritini, N., Sargos, P., Schick, U., Créhange, G., Cohen-Jonathan Moyal, E., Chevreau, C., & Khalifa, J. (2023). Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis. Cancers, 15(4), 1161. https://doi.org/10.3390/cancers15041161